Last reviewed · How we verify
NCT02929745
Single Cell Genomics of Psoriatic Skin
NA trial testing Skin biopsy in Psoriasis in 16 participants. Completed in 9 December 2020.
9 December 2020
Quick facts
| Lead sponsor | University of California, San Francisco |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | factorial |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 16 |
| Start date | 1 July 2016 |
| Primary completion | 9 December 2020 |
| Estimated completion | 9 December 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Skin biopsy
- Blood draw — full drug profile →
Conditions studied
- Psoriasis — all drugs for Psoriasis →
Sponsor
University of California, San Francisco
Who can join
18 and older, any sex, with Psoriasis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to understand how genetics play a role in psoriasis. Specifically, a genetic allele HLA-Cw6 is known to be associated with psoriasis, and this study aims to find out how it affects genetic and protein expression in patients with psoriasis, compared to healthy people, at a single-cell level using a novel flow cytometry and RNA-sequencing protocol.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A roadmap towards personalized immunology.
Delhalle S, Bode SFN, Balling R, Ollert M, et al · · 2018 · cited 42× · PMID 29423275 · DOI 10.1038/s41540-017-0045-9
Verify or expand the search:
- PubMed search for NCT02929745
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Skin biopsy
Trials testing the same drug.
- NCT07236736 — Evaluation of SPM™ Topical Cosmetic Application on Skin Appearance, Hydration, and Barrier Support in Healthy Adults · NA · not yet recruiting
- NCT07049588 — Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease · NA · recruiting
- NCT06539351 — A Pilot Study to Finetune Skin Processing Procedures in Recent Vaccinees, Prior to GeKoSkimm Study Initiation (GeKoSkimm · NA · completed
- NCT06467461 — Identification of Prodromal Neurodegeneration in Serotonergic-Induced REM Sleep Behavior Disorder · NA · recruiting
- NCT04872452 — Analysis of Cutaneous Nerve Biopsies in Gastrointestinal Motility Disorders · NA · withdrawn
Other recruiting trials for Psoriasis
Currently open trials in the same condition.
- NCT07471048 — A Study to Evaluate the Impact of a Magnolia Officinalis Dietary Supplement on Immune Biomarkers in Subjects With Psoria · NA · recruiting
- NCT07449234 — A Study of Guselkumab After Switching From Ustekinumab in Participants With Moderate to Severe Psoriasis · recruiting
- NCT07234838 — Effect of Anti-Psoriatic Biologics on Risk of Anogenital Warts (CONDYPSO) · recruiting
- NCT07194200 — Safety and Efficacy of Lactobacillus Plantarum for Psoriasis: A Randomized Double-Blind Placebo-Controlled Trial · Phase 2 · recruiting
- NCT07250997 — PALLAS Laser for Skin Diseases · NA · recruiting
Other University of California, San Francisco trials
Trials by the same sponsor.
- NCT05284773 — Screening for Acute Malnutrition · NA · withdrawn
- NCT04634851 — Video Home Visits for Dietary Counselling · NA · not yet recruiting
- NCT06065670 — Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a M · Phase 1, PHASE2 · not yet recruiting
- NCT07534098 — Intervention for Hearing Health Among Native Americans · NA · not yet recruiting
- NCT06960421 — Exercise-based Frailty Intervention in Lung Transplantation (XFIT) · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02929745 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of California, San Francisco
- Last refreshed: 23 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02929745.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing